Consequences of Undiagnosed and Untreated Pain

Published Online: Thursday, October 20, 2011
Follow Pharmacy_Times:
Watch as Michael R. Clark, MD, MPH, MBA, associate professor and director of the Chronic Pain Treatment Programs and department of Psychiatry and Behavioral Sciences at Johns Hopkins Medical Institutions, talks about the consequences of pain going undiagnosed or untreated—particularly in terms of the impact on quality of life, and the importance of engaging patients early.

Related Articles
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses what areas pharmacists should focus on during acute stroke codes.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses a pharmacist's door-to-door discharge role when managing an ischemic stroke patient.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses how pharmacists can enhance stroke care.
“Game changers” was the phrase Cedarville University School of Pharmacy Dean Marc Sweeney, PharmD, MDiv, used to describe his students.
Latest Issues
$auto_registration$